Complex multidisciplinary intervention to improve Initial Medication Adherence to cardiovascular disease and diabetes treatments in primary care (the IMA-cRCT study): mixed-methods process evaluation protocol

IntroductionMedication non-initiation, or primary non-adherence, is a persistent public health problem that increases the risk of adverse clinical outcomes. The initial medication adherence (IMA) intervention is a complex multidisciplinary intervention to improve adherence to cardiovascular and diab...

Full description

Saved in:
Bibliographic Details
Published inBMJ open Vol. 12; no. 10; p. e067468
Main Authors Corral-Partearroyo, Carmen, Sánchez-Viñas, Alba, Gil-Girbau, Montserrat, Peñarrubia-María, Maria Teresa, Aznar-Lou, Ignacio, Gallardo-González, Carmen, Olmos-Palenzuela, María del Carmen, Rubio-Valera, Maria
Format Journal Article
LanguageEnglish
Published England British Medical Journal Publishing Group 31.10.2022
BMJ Publishing Group LTD
BMJ Publishing Group
SeriesProtocol
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:IntroductionMedication non-initiation, or primary non-adherence, is a persistent public health problem that increases the risk of adverse clinical outcomes. The initial medication adherence (IMA) intervention is a complex multidisciplinary intervention to improve adherence to cardiovascular and diabetes treatments in primary care by empowering the patient and promoting informed prescriptions based on shared decision-making. This paper presents the development and implementation strategy of the IMA intervention and the process evaluation protocol embedded in a cluster randomised controlled trial (the IMA-cRCT) to understand and interpret the outcomes of the trial and comprehend the extent of implementation and fidelity, the active mechanisms of the IMA intervention and in what context the intervention is implemented and works.Methods and analysisWe present the protocol for a mixed-methods process evaluation including quantitative and qualitative methods to measure implementation and fidelity and to explore the active mechanisms and the interactions between the intervention, participants and its context. The process evaluation will be conducted in primary care centres and community pharmacies from the IMA-cRCT, and participants include healthcare professionals (general practitioners, nurses and community pharmacists) as well as patients. Quantitative data collection methods include data extraction from the intervention operative records, patient clinical records and participant feedback questionnaires, whereas qualitative data collection involves semistructured interviews, focus groups and field diaries. Quantitative and qualitative data will be analysed separately and triangulated to produce deeper insights and robust results.Ethics and disseminationEthical approval has been obtained from the Research Ethics Comittee (CEIm) at IDIAP Jordi Gol (codeCEIm 21/051 P). Findings will be disseminated through publications and conferences, as well as presentations to healthcare professionals and stakeholders from healthcare organisations.Trial registration numberNCT05026775.
Bibliography:Protocol
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Undefined-1
ObjectType-Feature-3
content type line 23
ISSN:2044-6055
2044-6055
DOI:10.1136/bmjopen-2022-067468